Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, discusses ongoing clinical trials of two treatments for patients infected with SARS-CoV-2 and how certain therapeutics will continue to play an important role in fighting the virus that causes COVID-19, even as vaccines become widely available.

Learn more about the COVID-19 HOPE Trial by clicking here.